Tetra Discovery Partners is a pharmaceutical drug development company development medicines for Alzheimer's Disease, Traumatic Brain Injury, and schizophrenia. The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.
Tetra designs drugs to treat memory loss and cognitive impairment by improving how the brain processes and stores information.
Tetra's promising drug for Alzheimer's Disease, BPN-14770, is being developed in partnership with the NIH Blueprint Therapeutics program.
|HQ||Grand Rapids, US|
|Size (employees)||8 (est)|
Tetra Discovery Partners total Funding
Tetra Discovery Partners latest funding size
Time since last funding
|2 years ago|
Tetra Discovery Partners investors
|Grand Angels, Biosciences Research and Commercialization Center (BRCC), Muskegon Angels, Michigan Emerging Technology Fund, Michigan, J &J Investments, Dolby Family Ventures, Apjohn ventures|
Tetra Discovery Partners has 257 Facebook Likes. The number of likes has increased 0.3% month over month and increased 7.6% quarter over quarter